<?xml version="1.0" encoding="UTF-8"?>
<svg height="774.0" width="586.7216994747475" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <path d=" M 449.9150085449219 559.6160278320312 L 575.7169799804688 559.6160278320312 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 550.1480102539062 L 252.0570068359375 550.1480102539062 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 277.5119934082031 550.1480102539062 L 312.4909973144531 550.1480102539062 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 417.37298583984375 527.6409912109375 L 573.7319946289062 527.6409912109375 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 245.25399780273438 518.1170043945312 L 280.1759948730469 518.1170043945312 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 393.1650085449219 486.1419982910156 L 428.0880126953125 486.1419982910156 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 504.67999267578125 373.6629943847656 L 539.60302734375 373.6629943847656 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 485.06500244140625 236.12600708007812 L 565.5120239257812 236.12600708007812 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 226.6580047607422 L 290.0409851074219 226.6580047607422 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 315.4960021972656 226.6580047607422 L 350.47601318359375 226.6580047607422 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 296.7309875488281 194.6269989013672 L 438.7460021972656 194.6269989013672 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 464.2019958496094 194.6269989013672 L 499.1239929199219 194.6269989013672 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 461.36700439453125 172.1199951171875 L 567.4959716796875 172.1199951171875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 162.65199279785156 L 273.99700927734375 162.65199279785156 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 299.4519958496094 162.65199279785156 L 334.375 162.65199279785156 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 221.49899291992188 130.6199951171875 L 377.8580017089844 130.6199951171875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <path d=" M 403.31298828125 130.6199951171875 L 438.2929992675781 130.6199951171875 Z " style="fill:none;stroke:#000000;stroke-width:1.0;"/>
  <text svg_rhmargin="211.512" x="204.888,209.264,211.512" y="91.28200000000004" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">7. </text>
  <text x="221.498,226.37,232.994,237.37,243.114,244.799,250.087,252.33499999999998,254.04,258.912,263.288,267.664,272.04,274.664,278.624,283.0,284.597,288.973,292.933,294.637,298.597,300.84499999999997,302.512,306.888,311.264,315.64,318.264,322.64,326.6,330.6,332.276,336.652,341.028,345.444,347.073,351.945,357.232,359.44,365.144,367.352,372.67999999999995,374.342,379.63,382.254,386.63,390.59,394.966,399.342,401.55,403.254,407.629,412.045,413.687,418.063,422.439,426.855,428.54,434.244,438.62,442.996,445.204,447.828,452.204,453.94800000000004,455.582,460.87,463.494,467.87,472.246,474.87,479.246,485.87,492.494,496.87,499.118,502.524,507.812,512.188,516.564,518.268,522.268,523.897,529.185,533.561,537.937,542.313,546.689,548.937,550.6,555.888,558.096,562.471,564.176,568.551" y="91.28200000000004" svg_rhmargin="571.215" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">FMoH E. Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme. Addis Ababa, Ethio-</text>
  <text x="221.498,225.874,227.578,231.954,234.202,235.899,240.275,244.651,249.027,253.403,255.611,259.986,264.245,268.621" y="100.80600000000004" svg_rhmargin="270.869" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">pia. 2008;207.</text>
  <text svg_rhmargin="211.512" x="204.888,209.264,211.512" y="113.78899999999999" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">8. </text>
  <text x="221.498,227.202,231.578,235.954,240.33,242.074,243.722,249.01,251.25799999999998,252.963,257.835,262.21,266.17,268.378,272.754,275.378,279.378,281.025,285.401,287.609,289.817,294.193,298.153,300.361,302.065,306.441,310.85699999999997,312.49,316.45,320.826,327.45,331.826,333.53,335.234,339.609,343.985,347.945,352.361,353.989,356.197,360.613,362.323,364.531,368.907,373.283,377.659,380.283,384.243,388.618,390.322,394.698,398.55,400.254,404.254,405.977,408.185,410.809,415.185,419.56,421.768,428.392,432.768,437.144,439.392,441.012,442.716,447.132,448.836,454.124,458.5,462.876,467.252,469.876,474.292,475.935,481.223,485.599,489.559,493.935,498.311,502.687,507.103,508.76,511.384,515.76,520.136,521.84,526.216,530.6320000000001,532.288,537.992,542.368,548.992,550.696,555.072,556.776" y="113.78899999999999" svg_rhmargin="561.192" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Chani K. Factors affecting compliance to tuberculosis treatment in Andara Kavango region Namibia</text>
  <text x="221.498,225.874,230.25,234.626,239.002" y="123.25599999999997" svg_rhmargin="241.25" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">2010.</text>
  <text svg_rhmargin="211.512" x="204.888,209.264,211.512" y="136.29600000000005" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">9. </text>
  <text x="221.498,227.202,228.906,233.282,237.658,242.034,244.69799999999998,246.387,252.091,256.467,258.715,260.39,262.598,266.974,269.182,273.558,276.181,280.141,284.517,288.893,291.101,292.704,297.08,301.456,305.456,307.161,309.369,313.745,316.409,318.103,320.311,324.686,329.062,333.438,336.062,340.022,344.398,345.996,350.372,354.332,356.036,360.036,361.756,365.716,370.092,374.468,376.676,379.3,383.676,385.42,387.041,391.417,395.793,400.209,401.894,406.27,407.974,409.678,416.302,418.006,422.382,426.758,428.966,430.67,435.046,439.422,441.67,445.038,447.246,451.622,453.83,458.206,460.83,465.206,469.581,471.789,473.493,477.869,482.245,486.621,488.365,489.995,495.699,500.075,501.779,506.155,510.57099999999997,512.219,517.506,521.882,526.258,527.962,532.338,536.298,538.546,540.225,545.097,549.473,553.848,558.224,560.848,564.808,569.184" y="136.29600000000005" svg_rhmargin="571.848" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Rieder HL. Interventions for tuberculosis control and elimination: International Union Against Tubercu-</text>
  <text x="221.498,223.202,227.578,231.538,233.242,237.242,238.904,243.28,247.655,252.071,253.757,258.133,262.509,266.885,271.301,272.975,278.679,280.383,284.343,288.719,293.095,297.055,301.471,303.136,308.423,312.799,315.423,317.127,321.087,323.335,325.019,329.395,333.771,338.147,342.523" y="145.76300000000003" svg_rhmargin="344.771" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">losis and Lung Disease Paris; 2002.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="158.803" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">10. </text>
  <text x="221.498,226.786,231.162,235.538,239.914,242.122" y="158.803" svg_rhmargin="246.538" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Sabate</text>
  <text svg_rhmargin="245.592" x="242.928,245.59199999999998" y="158.803" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">´ </text>
  <text x="248.201,253.489,255.737,257.442,262.73,267.106,271.482,275.857,278.481,282.857,287.233,291.061,295.477,297.183,299.391,303.807,305.517,307.221,311.597,315.973,320.349,322.973,325.181,329.557,332.181,338.84499999999997,340.497,342.705,347.081,351.457,354.081,358.456,362.832,364.536,368.912,372.755,375.003,376.723,381.099,385.059,386.763,391.138,395.514,399.89,403.85,408.266,409.888,412.096,416.472,419.13599999999997,420.887,425.263,429.223,431.431,433.135,437.511,441.887,444.135,447.532,455.068,459.444,462.068,463.772,468.188,469.869,475.573,479.949,484.324,486.029,488.236,492.652,494.304,500.512,503.135,507.511,511.887,516.263,517.967,521.927,526.303,528.511,530.215,534.498,538.874,541.1220000000001,542.833,547.208,551.584,555.96,560.336" y="158.803" svg_rhmargin="562.584" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">E. Adherence to long-term therapies: evidence for action: World Health Organization; 2003.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="171.78499999999997" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">11. </text>
  <text x="221.498,227.202,231.578,234.202,236.826,238.53,242.906,246.906,248.541,253.829,259.533,261.781,263.508,270.132,274.508,278.884,283.26,285.924,287.545,293.249,295.497,297.24,303.448,306.072,310.447,314.823,319.199,325.863,327.457,332.745,334.993,336.698,341.57,346.858,349.066,354.77,356.978,362.266,364.514,366.178,370.594,372.301,376.261,377.965,379.669,384.045,385.749,389.709,394.085,395.829,397.53,404.154,408.529,412.905,417.281,421.657,423.361,425.609,428.994,436.53,440.906,443.53,445.234,449.65,451.331,457.034,461.41,465.786,467.49,469.698,474.114,475.765,481.973,484.597,488.973,493.349,497.725,499.429,503.389,507.765,509.973,511.677,515.96,520.336,522.5840000000001,524.294,528.67,533.045,537.421,541.797" y="171.78499999999997" svg_rhmargin="544.045" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Harries AD, Maher D, Graham S. TB/HIV: a clinical manual: World Health Organization; 2004.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="184.76800000000003" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">12. </text>
  <text x="221.498,226.786,232.49,236.866,239.074,243.45,247.41,251.826,253.473,259.177,261.425,263.111,268.399,272.775,274.983,276.687,279.311,281.519,285.895,290.271,294.647,297.271,301.231,305.517,307.221,311.597,315.557,317.261,321.261,322.922,329.546,333.922,338.298,340.001,343.961,348.337,350.545,352.249,356.625,361.041,362.664,366.624,368.328,372.703,377.079,379.703,384.079,386.287,388.495,392.871,396.831,399.039,403.039,404.673,408.633,413.009,417.385,421.344,423.552,425.256,427.464,431.84,433.926,438.342,440.049,446.673,451.049,452.753,457.129,459.793,461.478,463.686,468.062,472.022,474.23,478.606,481.27,482.965,485.173,489.549,492.21299999999997,493.907,498.283,502.659,507.035,509.699,511.368,515.744,520.12,524.496,528.872,531.496,535.872,540.248,544.08,548.4960000000001,550.203,552.411" y="184.76800000000003" svg_rhmargin="556.827" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Awofeso N. Anti-tuberculosis medication side-effects constitute major factor for poor adherence to</text>
  <text x="221.498,223.706,228.082,232.458,236.834,239.458,243.418,247.794,249.498,253.874,257.725,259.429,263.429,265.152,267.36,269.984,274.36,278.736,280.944,287.568,291.944,296.32,298.528,300.776,302.399,307.687,312.063,313.767,315.471,319.847,322.055,323.758,328.174,329.838,334.214,336.462,338.172,340.38,344.756,349.17199999999997,350.871,358.407,362.783,365.407,367.111,371.527,373.151,378.855,383.231,387.607,389.311,391.519,395.935,397.642,403.85,406.474,410.85,415.226,419.602,421.306,425.266,429.504,431.712,433.416,437.791,442.167,444.41499999999996,446.115,450.491,454.866,459.242,463.618,465.866,467.545,471.921,476.297,478.505,483.793,486.417,492.12" y="194.29200000000003" svg_rhmargin="494.368" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tuberculosis treatment. Bulletin of the World Health Organization. 2008; 86:B-D.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="207.27499999999998" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">13. </text>
  <text x="221.498,227.706,230.33,234.706,239.082,243.458,245.162,249.122,253.498,255.706,257.41,261.694,266.11,267.817,275.353,281.057,283.305,284.994,292.53,298.234,304.48199999999997,306.14,308.764,313.14,317.516,321.892,324.516,326.764,328.421,332.797,337.173,341.549,345.925,348.173,349.851,354.227,355.931,360.307,364.683,369.059,370.80300000000005,372.471,374.679,379.055,383.431,387.807,390.43,394.39,398.766,400.364,404.74,408.7,410.404,414.404,416.125,420.085,424.46,428.836,431.044,433.668,438.044,439.748,441.996,443.62,447.58,451.956,454.58,458.54,462.916,464.62,466.324,468.028,472.404,476.78,480.641,485.017,487.265,488.975,493.351,495.055,499.431,503.807,508.183,509.887,514.263,518.639,520.8870000000001,522.537,524.745,526.449,530.825,535.201,539.577,543.537,545.241,549.617,553.888" y="207.27499999999998" svg_rhmargin="556.136" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Organization WH. WHO report 2008: global tuberculosis control: surveillance, planning, financing.</text>
  <text x="221.498,229.034,234.738,240.986,242.645,245.269,249.645,254.021,258.397,261.021,263.269,264.925,269.301,273.677,278.053,282.429,284.67699999999996,286.355,290.731,292.435,296.811,301.187,305.563,307.307,308.976,311.184,315.559,319.935,324.311,326.935,330.895,335.271,336.975,341.351,345.202,346.906,350.906,352.629,356.589,360.965,365.34,367.548,370.172,374.548,376.252,378.5,380.124,384.084,388.46,391.084,395.044,399.42,401.124,402.828,404.532,408.908,413.284,417.244,421.62,423.868,425.479,429.855,431.559,435.935,440.311,444.687,446.391,450.767,455.143,457.39099999999996,459.041,461.249,462.953,467.329,471.705,476.081,480.041,481.745,486.121,490.497,494.872,499.123,503.499,507.875" y="216.79899999999998" svg_rhmargin="510.123" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">WHO report 2008: global tuberculosis control: surveillance, planning, financing2008.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="229.78200000000004" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">14. </text>
  <text x="221.498,227.706,232.082,236.458,239.082,245.706,250.082,253.927,258.303,260.967,262.715,267.586,269.834,271.502,276.79,281.165,285.541,289.917,292.125,294.333,296.957,302.245,303.949,308.325,310.533,312.741,317.026,319.69,321.391,325.351,327.599,329.328,335.952,340.328,342.952,345.576,349.952,353.952,355.577,361.28,365.24,367.488,369.183,374.887,379.263,383.263,384.943,387.151,391.527,395.943,397.642,403.346,409.554,414.426,419.75399999999996,421.397,425.357,427.564,430.188,434.564,436.772,441.148,445.524,449.524,451.16,452.864,459.488,463.864,466.488,470.864,474.824,479.2,483.616,485.289,489.249,493.625,497.585,502.001,503.658,505.866,507.57,511.946,516.322,518.026,522.402,526.8180000000001,528.49,532.866,535.53,537.22,539.428,542.052,546.428,550.804,553.012,559.636,564.012,568.388" y="229.78200000000004" svg_rhmargin="570.636" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Obermeyer Z, Abbott-Klafter J, Murray CJ. Has the DOTS strategy improved case finding or treatment</text>
  <text x="221.498,225.458,229.834,233.794,237.754,242.13,246.09,250.05,254.466,256.081,261.369,265.785,267.476,271.852,278.476,282.852,284.556,287.18,288.884,292.844,297.22,298.96400000000006,300.641,305.017,308.977,312.937,317.313,321.273,325.233,331.857,336.074,340.45,342.658,344.906,346.619,351.907,356.283,360.659,365.98699999999997,367.652,373.86,378.236,382.612,384.86,386.531,390.907,395.283,399.658,404.034,406.282,407.961,412.337,414.961,419.337,421.961,424.169,428.544,432.92,437.296,441.672,445.945,448.193,449.913,454.289,456.497,458.705,463.081,467.041,469.249,471.457,473.665,478.041,482.285,483.989,486.197,490.573,493.197,497.572,499.78,504.156,508.532,510.74,515.116,519.492,523.868,528.149,530.357,532.061,536.437,540.813,543.437,547.813,552.189,553.893,556.101,560.477,564.852,569.138,573.514" y="239.30600000000004" svg_rhmargin="575.762" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">success? An empirical assessment. PLoS One. 2008; 3(3):e1721. https://doi.org/10.1371/journal.pone.</text>
  <text x="221.498,225.874,230.25,234.626,239.002,243.378,247.754,252.17,253.813,259.101,265.725,267.933,273.637,275.885,277.511,281.887,286.263,290.639,295.015,299.391,303.767,308.143" y="248.774" svg_rhmargin="312.559" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">0001721 PMID: 18320042</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="261.75699999999995" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">15. </text>
  <text x="221.498,226.786,228.49,232.906,234.595,239.883,242.131,243.836,248.708,253.124,254.834,260.122,262.37,264.075,268.946,273.322,277.698,282.114,283.747,289.035,291.283,292.988,298.276,302.652,307.028,311.444,313.114,318.818,321.066,322.808,330.344,334.72,339.096,343.512,345.146,350.433,352.681,354.386,360.09,364.466,368.882,370.6,375.888,378.13599999999997,379.841,384.217,386.465,388.119,392.495,394.199,396.447,398.153,403.857,408.233,412.193,416.569,418.273,422.649,427.025,433.648,438.024,442.4,444.64799999999997,446.285,450.661,455.037,459.453,461.082,465.042,469.418,471.122,472.826,477.201,481.577,483.785,485.489,489.865,494.281,495.948,500.324,502.572,504.282,508.698,510.404,512.612,516.988,521.364,525.74,528.364,532.324,536.7,538.297,542.673,546.633,548.337,552.337,554.058,560.682,565.058,569.434,571.138" y="261.75699999999995" svg_rhmargin="573.802" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Yin X, Tu X, Tong Y, Yang R, Wang Y, Cao S, et al. Development and validation of a tuberculosis medi-</text>
  <text x="221.498,225.458,229.834,232.042,233.746,238.122,242.538,244.176,248.552,252.928,257.303,261.679,264.303,268.679,273.055,277.015,281.431,283.067,287.027,290.987,295.363,297.067,301.443,303.691,305.347,310.635,315.011,319.387,324.715,326.38,332.588,336.964,341.34,343.58799999999997,345.258,349.634,354.01,358.386,362.762,365.01,366.688,371.064,373.688,378.064,382.44,385.064,387.272,391.648,396.024,400.4,404.673,409.049,413.425,415.673,417.372,421.748,423.956,426.164,430.54,434.5,436.708,438.916,441.012,445.388,449.764,451.468,453.676,458.052,460.676,465.052,467.26,471.636,476.012,478.22,482.596,486.877,491.253,495.629,497.836,499.54,503.916,508.292,510.916,515.292,519.668,521.372,523.58,527.866,532.242,536.618,540.994,543.202,547.577,551.953,556.212,560.588,564.964,569.34" y="271.28099999999995" svg_rhmargin="573.756" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">cation adherence scale. PLoS One. 2012; 7(12):e50328. https://doi.org/10.1371/journal.pone.0050328</text>
  <text x="221.498,226.786,233.41,235.618,241.322,243.57,245.253,249.629,254.005,258.381,262.757,267.133,271.388,275.764" y="280.80499999999995" svg_rhmargin="280.18" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">PMID: 23251363</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="293.787" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">16. </text>
  <text x="221.498,227.202,231.578,235.954,238.162,242.538,246.498,250.874,254.874,256.478,262.182,266.558,268.262,269.966,274.382,276.094,280.966,283.214,284.938,290.225,294.185,298.561,301.22499999999997,302.853,307.724,309.972,311.696,317.4,321.776,325.736,330.112,334.488,338.904,340.554,345.842,351.545,357.753,361.713,367.001,372.188,374.396,379.268,384.555,390.259,395.547,401.29100000000005,402.972,409.18,415.388,417.63599999999997,419.299,424.171,428.547,432.923,437.299,439.923,443.883,448.259,449.963,454.339,458.191,459.895,463.895,465.617,467.825,470.449,474.825,479.201,481.409,488.033,492.409,496.784,499.032,500.653,505.029,509.405,513.781,516.405,520.781,525.157,529.533,533.909,536.426,540.802,545.178,549.138,553.5540000000001,555.249,559.625,564.0" y="293.787" svg_rhmargin="568.416" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Habteyes Hailu T, Azar T, Davoud SHOJAEIZADEH GG. Tuberculosis treatment non-adherence and</text>
  <text x="221.498,223.202,227.578,231.538,233.786,235.502,237.71,242.126,243.779,245.987,250.363,252.067,253.771,258.147,263.89099999999996,265.606,269.982,274.398,276.094,280.47,287.093,291.469,295.845,300.261,301.888,306.76,312.08799999999997,313.794,318.17,322.546,324.754,326.458,330.834,335.21,337.418,341.418,343.048,348.752,350.456,352.664,357.08,358.752,363.128,365.792,367.482,373.186,374.89,377.098,381.474,385.85,390.226,392.474,394.184,399.888,402.096,407.424,409.094,410.798,415.214,416.918,421.294,425.67,429.63,434.006,435.71,440.086,444.357,446.061,450.437,454.853,456.547,460.507,464.882,469.258,473.634,475.842,478.466,480.17,484.546,488.506,490.75399999999996,492.376,496.792,498.499,502.459,506.419,510.379,512.587,516.963,523.586,527.962,530.17,531.874,535.874,537.503,540.127,544.503,548.463,550.167,554.543,560.247,562.495,564.149,566.357,568.981,573.357" y="303.255" svg_rhmargin="576.021" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Ira-</text>
  <text x="221.498,225.874,227.578,231.954,236.37,238.053,239.757,244.133,248.509,251.133,255.509,259.885,261.629,263.281,267.657,269.905,271.615,275.991,280.367,284.743,286.447,288.151,292.151,293.838,298.214,302.59,306.966,308.67,310.878,315.254,317.502,319.123,323.499,327.875,332.251,336.627,338.875,340.554,344.93,349.305,351.929,356.305,358.929,361.137,365.513,367.76099999999997,369.41,374.698,381.322,383.53,389.234,391.48199999999997,393.164,397.54,401.916,406.292,410.668,415.044,419.299,423.675" y="312.78" svg_rhmargin="428.091" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">nian journal of public health. 2015; 44(1):1. PMID: 26060770</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="325.762" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">17. </text>
  <text x="221.498,226.37,230.746,234.746,236.408,243.944,246.19199999999998,247.917,253.621,257.997,264.621,268.997,270.701,272.405,276.781,281.157,284.994,289.41,291.117,295.493,297.741,299.451,303.827,308.203,310.411,312.115,316.491,320.867,323.075,327.075,328.761,333.137,337.513,341.929,343.558,347.934,352.309,356.269,360.229,361.933,365.893,367.597,371.973,376.349,380.309,382.557,384.207,388.583,392.543,396.918,401.294,403.918,405.622,409.888,414.264,418.224,422.64,424.345,428.72,433.096,437.512,439.199,440.903,445.279,449.239,453.199,457.575,461.951,465.951,467.602,469.81,472.434,476.809,483.473,485.12,487.328,491.704,496.08,500.456,503.08,507.04,511.415,513.12,517.495,521.455,523.159,527.015,529.639,531.847,534.055,536.303,538.014,543.301,545.925,547.629,549.837,551.541,555.501" y="325.762" svg_rhmargin="559.917" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis-II. British</text>
  <text x="221.498,228.122,232.498,236.874,238.578,242.538,246.914,248.658,250.299,252.003,256.379,260.755,263.379,267.755,272.13,273.874,275.526,278.15,283.854,285.558,287.262,291.638,293.342,297.302,301.678,303.422,305.12,307.744,312.12,316.08,320.456,324.832,327.456,331.416,335.832,337.435,341.811,346.187,348.811,351.05899999999997,352.742,357.118,361.494,365.87,370.246,372.49399999999997,374.172,378.548,382.923,387.299,389.923,394.299,398.675,403.051,407.427,409.945,412.153,416.529,420.905,425.281" y="335.287" svg_rhmargin="427.529" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">medical journal (Clinical research ed). 1983; 287(6385):101.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="348.269" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">18. </text>
  <text x="221.498,227.706,232.082,236.458,239.082,243.458,250.082,254.458,257.082,258.689,263.065,269.729,271.388,278.012,283.3,285.548,287.205,292.493,294.197,298.573,302.949,307.365,309.032,315.24,320.528,322.776,324.396,329.268,331.892,333.596,337.556,341.972,343.614,347.574,353.278,355.526,357.221,362.509,366.884,369.508,372.132,373.836,378.212,380.836,384.836,386.475,390.851,395.227,399.643,401.271,403.479,407.855,411.815,413.519,415.223,416.927,419.135,423.511,425.719,430.095,432.622,436.622,438.348,442.724,444.972,446.625,451.001,455.377,459.753,464.129,466.753,471.129,475.505,479.465,483.881,485.46,487.668,492.084,493.736,498.608,503.936,505.642,507.85,510.474,514.85,519.226,521.434,528.058,532.434,536.81,539.058,540.621,542.326,546.7420000000001,548.445,552.821,557.197,559.405,561.109,565.485,569.861,572.069" y="348.269" svg_rhmargin="576.069" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients</text>
  <text x="221.498,225.874,230.29,231.987,235.947,240.323,244.699,248.659,253.035,259.659,261.363,263.571,267.817,272.193,274.441,276.15,281.022,286.34999999999997,288.056,292.432,296.808,301.224,302.909,308.613,310.821,316.149,317.819,320.027,322.651,327.027,331.403,333.611,340.235,344.611,348.987,351.195,353.443,355.066,359.48199999999997,361.189,365.565,369.941,374.317,376.021,377.725,379.933,384.309,386.517,388.221,392.181,396.597,398.266,402.226,404.434,408.81,413.186,417.146,419.394,421.057,426.345,432.968,438.712,440.389,444.765,449.141,453.517,455.221,456.925,460.925,462.556,466.932,471.308,475.684,477.388,479.596,483.972,486.21999999999997,487.897,492.273,496.649,501.025,505.401,507.649,509.328,513.703,518.079,520.703,525.079,527.703,529.911,534.287,538.663,543.039" y="357.794" svg_rhmargin="545.287" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">on concomitant TB and HIV treatment: a qualitative study. BMC public health. 2010; 10(1):651.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="370.776" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">19. </text>
  <text x="221.498,227.706,232.082,233.786,238.202,239.867,245.155,250.443,252.691,254.38,259.668,264.044,268.42,272.796,277.172,281.132,285.092,289.36,293.776,295.482,302.106,304.354,306.084,311.372,315.748,320.124,324.5,328.916,330.575,335.447,337.695,339.362,344.65,346.354,350.73,355.106,359.522,361.189,367.397,372.685,374.933,376.667,381.955,386.331,388.955,391.579,393.283,397.659,400.282,404.282,405.92,408.128,412.544,414.253,416.461,420.837,425.213,429.589,432.213,436.173,440.549,442.147,446.523,450.483,452.187,456.187,457.907,461.867,466.243,468.867,473.243,475.491,477.125,481.541,483.249,487.625,492.001,496.376,498.08,499.784,501.992,506.368,508.576,510.28,514.146,518.562,520.269,524.229,526.437,530.813,535.189,539.189,540.905,545.281,551.905,556.281,560.656" y="370.776" svg_rhmargin="565.072" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Gele AA, Sagbakken M, Abebe F, Bjune GA. Barriers to tuberculosis care: a qualitative study among</text>
  <text x="221.498,226.786,231.162,237.786,242.162,243.866,245.61,247.294,251.67,256.046,260.006,262.214,266.59,269.214,273.59,275.186,276.89,280.85,283.058,287.058,288.736,290.44,294.856,296.617,301.904,304.112,308.488,310.192,314.568,318.84,320.544,324.92,327.168,328.875,334.162,340.786,346.53,348.207,350.831,355.207,359.167,363.543,367.919,370.543,374.503,378.919,380.578,384.954,389.33,391.538,395.914,399.874,402.122,403.766,408.142,412.518,416.893,421.269,423.517,425.195,429.571,432.195,436.571,439.195,441.403,445.779,450.155" y="380.301" svg_rhmargin="452.403" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Somali pastoralists in Ethiopia. BMC research notes. 2010; 3(1):86.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="393.283" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">20. </text>
  <text x="221.498,226.786,231.162,235.538,239.914,244.29,248.25,252.21,256.478,260.894,262.601,269.225,271.473,273.202,278.074,280.698,282.402,286.362,290.778,292.421,296.381,302.085,304.33299999999997,306.028,311.316,313.02,317.396,321.771,326.187,327.854,334.062,336.31,338.002,343.29,347.666,350.29,352.914,354.618,358.994,361.618,365.618,367.256,371.632,376.008,380.424,382.109,386.485,390.861,395.237,399.613,401.317,405.693,408.317,412.317,413.97,415.674,420.09,421.793,424.001,428.377,432.793,434.493,441.117,445.493,449.869,454.245,458.621,462.997,469.621,473.997,478.26,480.508,482.228,486.604,488.852,490.505,492.713,497.089,501.465,505.841,508.465,512.425,516.801,518.505,522.881,526.841,528.545,532.545,534.158,536.366,538.99,543.366,547.742,549.95,556.574,560.95,565.326,567.5740000000001,569.195,570.899" y="393.283" svg_rhmargin="575.315" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Sagbakken M, Frich JC, Bjune G. Barriers and enablers in the management of tuberculosis treatment in</text>
  <text x="221.498,226.786,231.162,235.538,237.242,241.242,242.928,248.216,252.592,256.968,261.344,265.72,267.968,269.63,274.918,277.126,281.502,283.206,287.582,291.854,293.558,297.934,300.182,301.888,306.304,308.012,312.388,316.763,321.139,322.843,324.547,326.755,331.131,333.339,335.043,339.003,343.419,345.089,349.049,351.257,355.633,360.009,363.969,366.217,367.879,373.167,379.791,385.53499999999997,387.211,391.587,395.963,400.339,402.043,403.747,407.747,409.378,413.754,418.13,422.506,424.21,426.418,430.794,433.042,434.72,439.096,443.471,447.847,452.223,454.471,456.15,460.526,463.15,467.526,470.15,472.358,476.733,481.109" y="402.751" svg_rhmargin="483.357" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Addis Ababa, Ethiopia: a qualitative study. BMC public health. 2008; 8(1):11.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="415.79" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">21. </text>
  <text x="221.498,226.786,231.162,235.538,239.498,243.874,245.618,247.294,252.582,254.82999999999998,256.535,261.823,268.447,272.822,277.238,278.872,285.08,287.328,289.02,294.308,298.684,300.892,305.268,306.972,311.348,315.307,319.683,326.21,330.586,333.25,334.941,340.645,342.893,344.635,350.339,354.715,356.923,361.299,363.923,370.547,372.251,376.627,381.003,385.227,387.435,391.435,393.164,397.54,399.788,401.498,405.874,410.25,414.625,417.289,418.959,423.335,427.711,432.087,436.463,439.087,443.463,447.839,451.799,456.215,457.794,460.002,464.418,466.127,470.503,474.879,477.087,478.791,481.415,483.623,487.999,492.375,496.751,499.375,503.335,507.711,509.327,513.703,517.663,519.367,523.367,525.031,527.239,529.863,534.239,538.615,540.823,547.447,551.823,556.199,558.447,560.067,561.771" y="415.79" svg_rhmargin="566.187" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Bagchi S, Ambe G, Sathiakumar N. Determinants of poor adherence to anti-tuberculosis treatment in</text>
  <text x="221.498,228.122,232.498,239.122,243.498,247.874,249.578,251.826,253.473,255.681,260.057,264.433,266.137,270.513,272.76099999999997,274.45,276.658,281.034,283.242,287.617,290.241,294.617,298.884,301.092,302.796,307.172,311.548,315.924,317.668,319.35,321.054,325.43,329.806,332.43,336.806,341.182,342.92600000000004,344.578,348.954,351.202,352.912,357.288,359.912,364.288,368.248,372.624,377.0,379.208,380.912,384.871,389.287,390.896,397.52,401.896,406.272,407.976,411.936,413.64,418.016,422.392,424.64,426.273,430.648,435.024,439.4,443.776,446.024,447.703,452.079,454.703,459.079,461.703,463.91,468.286,472.662,477.038,479.286,480.924,486.212,492.836,495.044,500.748,502.996,504.679,509.055,513.431,517.807,522.183,526.558,530.814,535.19" y="425.258" svg_rhmargin="539.606" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Mumbai, India. International journal of preventive medicine. 2010; 1(4):223. PMID: 21566777</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="438.298" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">22. </text>
  <text x="221.498,226.37,230.746,234.706,236.914,241.29,245.666,250.042,254.418,258.689,262.649,267.025,271.441,273.146,279.354,281.602,283.294,289.917,294.293,298.669,303.045,304.749,309.165,310.789,316.997,319.245,320.938,325.314,329.69,334.066,338.442,342.402,346.362,350.778,352.402,359.026,361.274,363.004,368.292,372.668,377.044,381.419,384.043,388.419,392.795,396.622,401.038,402.745,404.953,409.36899999999997,411.079,416.367,420.743,422.951,424.655,427.279,429.487,433.863,438.239,442.615,445.239,449.199,453.485,455.189,459.565,463.525,465.229,469.229,470.89,473.098,475.721,480.097,484.473,486.681,493.305,497.681,502.057,504.305,505.926,510.302,514.678,519.094,520.779,522.987,525.611,529.987,534.363,536.571,543.195,547.571,551.947,554.195,555.815,560.191,564.567,566.775" y="438.298" svg_rhmargin="569.439" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Tesfahuneygn G, Medhin G, Legesse M. Adherence to Anti-tuberculosis treatment and treatment out-</text>
  <text x="221.498,225.458,229.834,236.458,240.834,244.834,246.5,250.876,257.5,261.876,266.252,270.668,272.295,274.503,278.879,283.255,287.631,290.255,294.215,298.591,300.295,304.671,308.522,310.226,314.226,315.948,320.324,324.7,326.908,328.612,332.988,337.364,339.572,343.572,345.202,346.906,351.322,353.025,358.313,360.017,364.393,371.017,375.393,377.601,382.017,383.696,389.4,391.104,395.064,397.272,399.896,401.6,405.56,407.678,409.926,411.646,416.021,420.397,423.021,425.229,429.605,433.981,438.357,442.317,444.565,446.228,451.516,453.724,458.1,459.804,464.18,468.452,470.156,474.532,476.78,478.486,483.774,490.398,496.14200000000005,497.819,500.443,504.819,508.779,513.155,517.531,520.155,524.115,528.5310000000001,530.19,534.566,538.942,541.15,545.526,549.486,551.734,553.377,557.753,562.129,566.505,570.881" y="447.765" svg_rhmargin="573.129" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">comes among tuberculosis patients in Alamata District, northeast Ethiopia. BMC research notes. 2015;</text>
  <text x="221.498,225.874,228.498,232.874,235.498,237.706,242.082,246.458,250.834" y="457.289" svg_rhmargin="253.082" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">8(1):503.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="470.272" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">23. </text>
  <text x="221.498,227.706,233.41,238.698,244.026,245.707,250.995,256.283,258.531,260.219,265.923,271.211,276.499,281.787,286.072,291.36,293.568,298.89599999999996,300.584,307.208,309.456,311.187,316.475,321.763,323.971,329.71500000000003,331.369,336.657,338.905,340.61,345.898,348.105,353.393,358.681,363.553,368.881,370.544,375.832,378.08,379.784,386.408,391.696,397.4,403.608,408.896,414.084,419.788,425.116,426.84,432.128,434.376,436.08,440.952,446.24,451.528,457.232,462.976,464.654,469.942,472.19,473.894,478.27,480.518,482.172,486.548,488.252,490.5,492.206,497.494,502.782,508.07,513.358,518.646,523.934,530.474,535.762,541.465,546.3770000000001,548.105,554.313" y="470.272" svg_rhmargin="559.225" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">GUBE AA, DEBALKIE M, SEID K, BISETE K, MENGESHA A, ZEYNU A, et al. ASSESSMENT OF</text>
  <text x="221.498,226.786,232.49,237.362,239.60999999999999,241.284,246.156,251.484,253.19,258.894,264.598,270.302,276.55,278.191,283.895,290.103,295.807,298.431,303.719,309.423,315.041,320.329,326.033,331.321,337.025,342.729,348.05699999999996,349.737,355.025,360.729,366.47299999999996,368.163,370.371,375.243,380.57099999999997,382.279,387.567,392.855,398.142,404.35,409.945,412.153,417.441,422.313,427.6,433.34400000000005,435.06,439.932,445.219,450.923,455.696,461.904,467.608,472.936,474.631,479.919,486.543,492.751,498.455,504.703,506.38,511.251,516.579,518.228,523.516,528.804,533.676,535.884,541.172,546.876,551.748" y="479.796" svg_rhmargin="557.076" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ANTI TB DRUG NON-ADHERENCE AND ITS ASSOCIATED FACTORS AMONG TB PATIENTS</text>
  <text x="221.498,226.786,231.658,236.53,241.818,247.522,253.133,255.341,261.045,267.293,269.007,273.879,279.207,280.913,286.617,290.993,293.201,298.905,301.112,306.816,312.14399999999995,313.794,316.002,321.746,323.432,328.72,334.424,339.712,345.03999999999996,346.733,353.357,355.565,361.268,366.972,372.716,374.342,380.55,386.758,392.046,397.334,403.038,408.742,415.274,420.562,426.266,431.138,436.426,440.842,442.487,448.191,453.479,458.766,463.142,468.014,473.75800000000004,475.425,477.633,483.337,488.625,493.496,495.704,500.576,506.28,511.152,513.36,519.475,525.179,530.467,532.715,534.386,539.673,545.881,551.585,556.457,562.161" y="489.264" svg_rhmargin="564.825" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ATTENDING TB CLINICS IN ARBA MINCH GOVERNMENTAL HEALTH INSTITUTIONS, SOUTH-</text>
  <text x="221.498,226.786,232.49,238.234,239.924,245.212,250.084,255.787,257.995,264.203,269.491,271.699,276.887" y="498.788" svg_rhmargin="279.135" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ERN ETHIOPIA.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="511.771" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">24. </text>
  <text x="221.498,226.786,231.162,235.122,239.498,241.74599999999998,243.439,248.727,254.935,257.183,258.859,264.147,268.523,270.227,272.435,276.851,278.531,285.155,290.027,292.275,293.952,300.16,304.536,306.24,310.616,316.36,317.99,323.278,328.566,330.81399999999996,332.502,338.71,343.086,347.462,350.086,354.462,361.086,365.462,368.086,369.693,374.069,380.733,382.449,387.737,392.609,394.85699999999997,396.566,402.27,406.646,411.062,412.723,418.011,422.387,426.763,431.139,433.763,438.139,442.515,446.475,450.891,452.521,456.897,461.273,465.689,467.318,469.022,471.23,475.23,476.956,482.66,487.036,491.412,493.62,496.244,497.948,502.324,506.7,508.908,510.518,514.894,519.3100000000001,521.006,525.878,530.254,534.214,536.422,540.797,543.422,547.422,549.069,551.277,555.6930000000001,557.403,562.691,567.067,569.275,570.979" y="511.771" svg_rhmargin="573.643" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Yusuf KO, Seifu MF, Gelaw BK, Gebremariam ET. Non Adherence and its Contributing Factors to Anti-</text>
  <text x="221.498,226.37,231.698,233.404,239.108,241.732,246.108,250.524,252.169,253.873,258.289,259.993,265.697,270.073,271.777,273.481,277.857,280.481,284.857,289.233" y="521.2950000000001" svg_rhmargin="293.649" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">TB Drug in Childrena</text>
  <text svg_rhmargin="292.704" x="290.04,292.704" y="521.2950000000001" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ˆ </text>
  <text svg_rhmargin="299.483" x="293.555,299.483" y="521.2950000000001" style="fill:#000000;font-family:AEHIFE+FreeSerif;font-size:8.0px;font-style:NORMAL;font-weight:normal;">€ </text>
  <text x="301.208,305.208,306.935,311.311,313.55899999999997,315.212,320.499,324.875,329.251,335.875,340.291,341.97,347.674,352.05,354.258,358.634,361.258,363.882,368.258,370.002,371.62,377.324,381.7,385.66,390.036,391.74,393.948,398.324,400.028,402.276,403.935,410.143,412.767,417.143,423.767,425.471,429.847,432.09499999999997,433.756,439.044,441.252,445.628,447.331,451.707,456.083,457.787,462.163,464.411,466.07,472.278,473.982,478.358,482.734,487.11,488.85400000000004,490.505,494.465,498.841,503.217,505.841,510.217,514.593,516.337,518.001,522.377,524.625,526.335,532.959,537.335,541.711,543.415,547.375,551.751" y="521.2950000000001" svg_rhmargin="553.495" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">s at Adama Referral Hospital, Oromia, Ethiopia. Global Journal of Medical</text>
  <text x="221.498,227.202,231.578,235.538,239.914,244.29,246.914,250.874,255.25,257.498,259.143,263.519,267.895,272.271,276.646" y="530.7629999999999" svg_rhmargin="278.894" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Research. 2015.</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="543.802" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">25. </text>
  <text x="221.498,229.034,233.41,235.114,241.738,246.154,247.804,252.676,257.548,259.796,261.523,266.811,268.515,275.139,279.515,282.179,283.804,291.34,296.628,298.876,300.585,305.872,310.248,312.456,314.20000000000005,315.892,320.764,323.012,324.736,330.944,335.32,339.28,343.656,347.616,351.992,357.736,359.318,365.022,370.31,372.558,374.285,379.157,383.533,387.949,389.592,393.968,396.592,400.968,404.928,409.304,411.008,415.384,419.76,423.72,428.136,429.788,434.164,438.54,442.956,444.641,446.849,451.225,455.185,457.393,461.769,464.393,468.393,470.039,474.415,478.375,482.335,486.711,490.671,492.375,496.751,498.839,503.215,507.631,509.328,511.536,515.911,518.5749999999999,520.269,524.645,529.021,531.229,532.933,535.557,537.765,542.141,546.517,550.893,553.517,557.477,561.853,563.469,567.844" y="543.802" svg_rhmargin="570.508" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Woimo TT, Yimer WK, Bati T, Gesesew HA. The prevalence and factors associated for anti-tuberculo-</text>
  <text x="221.498,225.458,227.162,231.162,232.837,235.045,237.669,242.045,246.421,248.629,255.253,259.629,264.005,266.253,267.93,272.306,276.682,281.058,283.682,288.058,292.308,296.684,301.06,303.684,308.06,312.436,316.396,320.812,322.468,326.844,333.468,337.844,342.22,346.636,348.263,352.639,357.015,358.719,365.343,369.719,374.095,378.471,381.095,385.095,386.758,388.966,393.342,397.718,402.094,404.718,408.678,413.054,414.65,419.026,422.986,424.69,428.69,430.411,434.787,439.163,441.371,443.075,447.451,451.827,454.035,458.035,459.664,461.368,465.784,467.488,471.864,476.24,480.616,482.32,484.024,488.024,489.712,494.088,498.464,502.84,504.544,506.752,511.168,512.786,516.746,521.122,523.746,528.162,529.85,532.058,536.434,540.394,542.098,543.802,545.505,547.714,549.417,553.793,557.793,559.444,561.148" y="553.27" svg_rhmargin="565.564" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">sis treatment non-adherence among pulmonary tuberculosis patients in public health care facilities in</text>
  <text x="221.498,226.786,231.162,235.538,237.746,242.162,243.836,249.124,251.332,255.708,257.411,261.787,266.163,267.867,272.243,274.491,276.15,280.566,282.274,286.234,288.858,293.233,297.193,301.153,303.777,307.615,311.991,315.951,318.159,319.863,324.239,328.615,332.991,334.735,336.415,340.374,342.582,346.958,351.334,355.294,357.542,359.205,364.493,371.117,376.861,378.537,382.913,387.289,391.665,393.369,395.073,399.073,400.761,405.137,409.513,413.889,415.593,417.801,422.177,424.425,426.045,430.421,434.797,439.173,443.549,445.79699999999997,447.476,451.852,456.227,458.851,463.227,465.851,468.059,472.435,476.811,481.187,483.435,485.063,489.439,491.647,493.855,498.231,502.191,504.399,506.607,508.815,513.191,517.435,519.139,521.347,525.723,528.347,532.723,534.931,539.306,543.682,545.89,550.266,554.642,559.018,563.299" y="562.794" svg_rhmargin="565.547" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">South Ethiopia: a cross-sectional study. BMC public health. 2017; 17(1):269. https://doi.org/10.1186/</text>
  <text x="221.498,225.458,229.834,234.21,238.586,242.962,247.338,249.962,254.338,258.714,262.941,265.565,269.941,274.317,278.693,283.069,285.693,290.109,291.798,297.085,303.709,305.917,311.621,313.86899999999997,315.495,319.871,324.247,328.623,332.999,337.375,341.75,346.126" y="572.262" svg_rhmargin="350.542" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">s12889-017-4188-9 PMID: 28320351</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="585.3009999999999" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">26. </text>
  <text x="221.498,226.786,231.162,235.538,239.914,244.29,248.706,250.356,255.644,257.892,259.596,267.132,271.508,275.884,280.3,281.933,287.637,292.509,294.757,296.446,303.07,307.446,311.822,313.526,317.486,321.862,324.07,325.774,330.15,334.566,336.188,340.564,344.94,349.316,353.692,356.316,360.692,365.068,369.028,373.444,375.079,379.455,383.831,388.247,389.932,391.636,393.844,397.844,399.514,403.89,408.266,410.474,414.85,417.474,424.097,425.801,430.177,434.553,438.929,441.137,445.137,446.739,451.115,457.739,462.115,466.491,470.907,472.59,476.966,481.342,483.55,485.254,489.63,494.006,496.214,500.214,501.844,506.22,510.636,512.332,516.292,520.668,525.044,529.004,533.38,540.004,541.708,543.797,548.173,552.549" y="585.3009999999999" svg_rhmargin="554.797" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Kebede A, Wabe NT. Medication adherence and its determinants among patients on concomitant</text>
  <text x="221.498,223.706,228.082,232.458,236.834,239.458,243.418,247.794,249.498,253.874,257.725,259.429,263.429,265.152,269.528,273.904,278.32,280.006,284.382,288.758,290.966,292.67,295.293,299.669,301.877,304.501,308.877,312.717,314.421,317.045,321.421,323.165,324.906,327.114,331.49,335.866,338.49,342.866,347.242,351.242,352.856,354.56,358.976,360.679,365.967,370.343,374.719,376.927,381.343,383.016,390.552,394.928,398.888,401.13599999999997,402.802,408.09,410.298,414.674,416.378,420.754,425.129,426.833,431.209,433.457,435.117,440.82,445.196,447.82,450.028,454.444,456.093,461.381,468.005,472.381,475.005,476.709,480.669,485.045,489.461,491.129,492.833,497.209,501.585,504.208,508.584,512.96,514.7040000000001,516.357,520.733,522.981,524.691,531.315,535.691,540.067,541.771,545.731,550.107,551.851,553.491,557.451,561.411,563.115" y="594.769" svg_rhmargin="565.779" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">tuberculosis and antiretroviral therapy in South West Ethiopia. North American journal of medical sci-</text>
  <text x="221.498,225.874,230.25,234.21,238.586,242.546,244.79399999999998,246.444,250.82,255.196,259.572,263.947,266.195,267.873,272.249,274.873,279.249,281.873,284.081,288.457,292.833,295.081,296.73,301.106,303.314,305.522,309.898,313.858,316.066,318.274,320.482,324.736,329.112,330.816,333.024,337.4,340.024,344.4,346.608,350.984,355.36,357.568,361.944,366.32,370.601,374.977,377.184,381.56,385.936,390.312,394.688,397.312,401.688,406.064,410.44,414.707,416.915,421.291,425.667,430.043,434.419,438.835,440.446,445.734,452.358,454.566,460.27,462.518,464.2,468.576,472.952,477.328,481.704,486.08,490.456,494.832" y="604.293" svg_rhmargin="499.248" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ences. 2012; 4(2):67. https://doi.org/10.4103/1947-2714.93376 PMID: 22408750</text>
  <text svg_rhmargin="211.523" x="200.523,204.899,209.275,211.523" y="617.2760000000001" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">27. </text>
  <text x="221.498,226.786,231.162,235.538,238.162,242.538,244.242,248.658,250.299,255.587,260.875,263.123,264.812,269.188,270.892,275.268,279.644,281.852" y="617.2760000000001" svg_rhmargin="283.596" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Shargie EB, Lindtj</text>
  <text x="283.556" y="617.2760000000001" svg_rhmargin="288.444" style="fill:#000000;font-family:FTHCNZ+ArialMT;font-size:8.0px;font-style:NORMAL;font-weight:normal;">ø</text>
  <text x="288.404,291.028,295.444,297.127,302.415,304.663,306.368,312.072,316.448,318.656,323.032,325.656,332.279,333.983,338.359,342.735,347.016,349.224,353.224,354.897,359.273,361.521,363.23,365.438,368.062,372.438,376.814,379.022,385.646,390.022,394.398,396.646,398.267,402.643,407.019,411.394,415.77,418.394,422.77,427.146,431.106,435.522,437.157,441.533,448.157,452.533,456.909,461.325,462.953,466.913,473.537,477.913,482.289,484.913,487.537,491.913,496.175,500.135,501.839,504.047,505.751,509.711,514.1270000000001,515.79,520.166,524.542,526.246,532.87,537.246,541.622,545.998,548.622,552.622,554.285,556.493,560.869,565.245,569.62,572.245" y="617.2760000000001" svg_rhmargin="574.909" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">rn B. Determinants of treatment adherence among smear-positive pulmonary tuber-</text>
  <text x="221.498,225.458,229.834,231.538,235.914,239.874,241.578,245.578,247.237,251.613,255.989,258.197,259.901,264.277,268.653,270.861,274.861,276.491,278.195,282.611,284.314,289.602,293.978,298.354,300.562,304.938,309.314,311.938,316.354,317.99,323.278,325.486,329.862,331.566,335.942,340.318,342.022,346.398,348.646,350.305,355.593,359.969,364.345,369.673,371.337,377.961,382.337,386.713,388.417,392.377,394.081,398.457,402.833,405.081,406.714,411.09,415.466,419.842,424.218,426.466,428.144,432.52,435.144,439.52,442.144,444.352,448.728,453.104,457.48,459.728,461.365,465.741,467.949,470.157,474.533,478.493,480.701,482.909,485.117,489.372,493.748,495.452,497.66,502.036,504.66,509.036,511.244,515.62,519.996,522.204,526.579,530.955,535.236,539.612,541.82,543.524,547.9,552.276,554.9,559.276,563.652,565.356" y="626.8" svg_rhmargin="567.604" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">culosis patients in Southern Ethiopia. PLoS medicine. 2007; 4(2):e37. https://doi.org/10.1371/journal.</text>
  <text x="221.498,225.874,232.498,236.874,241.25,243.458,247.834,252.21,256.478,260.854,265.23,269.606,274.022,275.697,280.985,287.609,289.817,295.521,297.769,299.451,303.827,308.203,312.579,316.955,321.331,325.587,329.963" y="636.268" svg_rhmargin="334.379" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">pmed.0040037 PMID: 17298164</text>
  <text svg_rhmargin="211.523" x="200.524,204.899,209.275,211.523" y="649.251" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">28. </text>
  <text x="221.498,226.786,231.162,235.538,239.914,244.32999999999998,245.99,251.278,256.566,258.81399999999996,260.504,265.792,267.495,271.871,276.247,280.663,282.33,287.618,292.906,295.154,296.843,302.131,306.507,310.467,314.883,316.572,322.276,327.98,330.228,331.879,336.751,341.127,342.831,347.207,351.167,355.58299999999997,357.278,362.565,369.189,371.437,373.095,378.799,383.175,387.551,390.175,394.551,398.927,403.303,407.679,410.303,414.678,419.054,422.871,427.287,428.994,431.202,435.618,437.328,441.704,446.08,448.288,449.992,452.616,454.824,459.199,463.575,467.951,470.575,474.535,478.911,480.527,484.903,488.863,490.567,494.567,496.231,498.439,501.063,505.439,509.815,512.023,518.647,523.023,527.399,529.647,531.267,535.643,540.019,544.4350000000001,546.121,550.497,554.873,557.081,561.457,564.081,570.705,572.409" y="649.251" svg_rhmargin="575.073" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Adane AA, Alene KA, Koye DN, Zeleke BM. Non-adherence to anti-tuberculosis treatment and determi-</text>
  <text x="221.498,225.874,230.25,234.626,236.874,238.563,240.771,245.147,249.107,251.315,255.691,258.315,262.315,263.962,268.338,274.962,279.338,283.714,288.13,289.757,294.133,298.509,300.717,302.421,306.797,311.173,313.381,317.381,319.067,324.771,326.475,328.683,333.099,334.771,336.979,341.355,345.731,350.107,352.73,356.69,361.066,362.664,367.04,371.0,372.704,376.704,378.424,380.128,384.544,386.248,390.624,395.0,397.623,399.831,404.207,409.911,414.287,418.247,420.495,422.134,427.422,429.63,434.006,435.71,440.086,444.357,446.061,450.437,452.685,454.392,459.68,461.384,465.76,471.08799999999997,472.818,477.194,481.57,485.946,488.194,489.826,494.201,498.577,502.953,507.329,509.577,511.255,515.631,518.255,522.631,527.007,529.631,531.839,536.215,540.591,544.966,549.239,553.615,557.991" y="658.775" svg_rhmargin="560.239" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">nant factors among patients with tuberculosis in northwest Ethiopia. PloS one. 2013; 8(11):e78791.</text>
  <text x="221.498,225.874,228.082,230.29,234.666,238.626,240.834,243.042,245.25,249.626,254.002,255.706,257.914,262.29,264.812,269.188,271.396,275.772,280.148,282.356,286.732,291.108,295.37,299.745,301.953,303.657,308.033,312.409,315.033,319.409,323.785,325.489,327.697,332.073,336.358,340.734,345.11,347.318,351.694,356.07,360.446,364.822,369.069,373.445,377.861,379.558,384.846,391.47,393.678,399.382,401.63,403.312,407.688,412.064,416.44,420.816,425.192,429.568,433.944" y="668.3" svg_rhmargin="438.36" style="fill:#3a5aa6;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">https://doi.org/10.1371/journal.pone.0078791 PMID: 24244364</text>
  <text svg_rhmargin="211.523" x="200.524,204.9,209.275,211.523" y="681.282" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">29. </text>
  <text x="221.498,226.786,228.49,231.114,235.49,239.49,241.171,246.459,248.707,250.412,255.284,259.66,263.62,265.324,269.74,271.388,276.26,278.508,280.232,285.936,290.312,294.272,298.648,300.352,304.728,309.104,313.52,315.155,320.027,322.275,323.999,328.871,333.247,337.207,339.415,343.791,347.791,349.398,356.022,358.27,359.999,365.287,366.991,368.695,373.071,377.031,381.407,385.68,390.056,394.432,397.056,401.472,403.199,408.487,410.735,412.383,419.007,423.383,425.087,429.463,433.839,438.215,440.423,444.839,446.512,451.8,454.048,455.753,461.041,465.417,469.793,474.169,476.793,481.169,485.545,489.372,493.788,495.494,497.702,502.118,503.829,508.205,512.58,514.788,516.492,519.116,521.324,525.7,530.076,534.452,537.076,541.036,545.412,547.028,551.404,555.364,557.068" y="681.282" svg_rhmargin="561.068" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Kiros Y, Teklu T, Desalegn F, Tesfay M, Klinkenberg E, Mulugeta A. Adherence to anti-tuberculosis</text>
  <text x="221.499,223.706,226.33,230.706,235.082,237.29,243.914,248.29,252.666,254.914,256.535,258.239,262.655,264.359,269.231,270.935,275.311,277.935,282.311,286.271,288.519,290.21,295.914,300.29,302.914,305.122,309.498,313.874,316.498,320.914,322.525,327.813,330.021,334.397,336.101,340.477,344.853,346.557,350.933,353.181,354.84,360.128,364.504,368.88,370.584,372.288,376.288,377.971,382.347,386.723,391.099,392.803,395.011,399.427,401.044,405.42,409.38,411.588,413.292,417.668,422.044,424.292,425.99,430.366,434.741,439.117,443.493,445.741,447.362,451.738,454.362,458.738,461.362,463.57,468.858,473.234,477.61,481.986,487.274,491.65" y="690.75" svg_rhmargin="493.898" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">treatment in Tigray, Northern Ethiopia. Public health action. 2014; 4(3):S31–S6.</text>
  <text svg_rhmargin="211.523" x="200.524,204.9,209.275,211.523" y="703.789" style="fill:#000000;font-family:Helvetica-Bold;font-size:8.0px;font-style:NORMAL;font-weight:bold;">30. </text>
  <text x="221.499,226.786,228.994,230.698,234.658,239.034,243.45,245.14,250.012,252.26,253.927,259.215,263.591,267.551,271.511,275.927,277.624,282.912,285.15999999999997,286.809,292.513,296.889,301.265,303.889,309.177,313.553,317.929,322.304,324.928,329.304,333.58,337.54,341.956,343.671,345.879,350.295,351.949,357.237,361.613,363.821,365.525,368.149,373.021,378.349,380.012,385.716,388.34,392.716,397.092,401.092,402.802,407.178,411.554,415.96999999999997,417.655,419.863,422.071,426.071,427.746,433.034,435.658,440.034,444.41,446.114,450.074,452.282,456.658,459.282,463.282,464.88,469.256,475.88,480.256,484.632,489.048,490.732,495.604,500.892,503.1,508.804,511.012,516.34,518.001,523.705,528.081,530.705,532.913,537.289,539.497,543.873,547.833,549.919,554.295" y="703.789" svg_rhmargin="558.711" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Eticha T, Kassa E. Non-Adherence to Anti-TB Drugs and Its Predictors among TB/HIV Co-Infected</text>
  <text x="221.499,226.786,231.162,233.37,235.074,239.45,243.826,246.034,250.034,251.66,253.364,257.78000000000003,259.483,266.107,270.483,274.443,278.819,280.523,282.227,286.603,288.851,290.494,295.782,297.99,302.366,304.069,308.445,312.821,314.525,318.901,321.149,322.808,326.768,331.144,335.52,338.144,342.52,346.896,348.64000000000004,350.305,354.681,356.929,358.638,363.926,365.63,370.006,374.382,378.758,383.134,384.838,388.685,392.645,394.349,398.349,400.081,404.457,408.833,413.249,414.934,420.222,421.926,426.302,432.926,437.302,441.58,443.284,447.244,448.948,453.324,457.7,459.948,461.649,466.025,470.401,474.777,479.153,481.401,483.078,487.454,490.078,494.454,497.078,499.286,503.662,508.038" y="713.2570000000001" svg_rhmargin="510.286" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Patients in Mekelle, Ethiopia. Journal of Bioanalysis and Biomedicine. 2014; 6(6):61.</text>
  <path d=" M 576.0 737.0999755859375 L 36.0 737.0999755859375 L 36.0 737.5999755859375 L 576.0 737.5999755859375" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d="M449.915 240.383 L575.716 240.383 M221.498 249.851 L252.057 249.851 M277.511 249.851 L312.49 249.851 M417.372 272.359 L573.731 272.359 M245.253 281.882 L280.175 281.882 M393.165 313.858 L428.088 313.858 M504.679 426.337 L539.603 426.337 M485.065 563.873 L565.512 563.873 M221.498 573.341 L290.04 573.341 M315.496 573.341 L350.476 573.341 M296.73 605.373 L438.746 605.373 M464.201 605.373 L499.123 605.373 M461.367 627.88 L567.495 627.88 M221.498 637.348 L273.997 637.348 M299.451 637.348 L334.375 637.348 M221.498 669.38 L377.858 669.38 M403.312 669.38 L438.292 669.38 M576.0 62.9 L36.0 62.9 L36.0 62.4 L576.0 62.4 " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <rect style="stroke:blue;stroke-width:0.3;" x="36.0" y="35.042" height="23.698" width="107.15" title="14"/>
  <text x="36.0" y="35.042" class="image" id="image.14.1" width="107" height="23">image.14.1.36_143.35_59</text>
  <text x="279.836,285.124,287.748,292.124,296.084,300.46,302.164,306.54,310.916,314.758,319.174,320.881,325.257,329.633,334.049,335.734,340.11,344.486,346.694,351.07,353.694,360.318,362.022,366.292,370.668,375.044,377.252,381.252,382.96,387.335,389.58299999999997,391.293,395.669,400.045,402.253,403.957,406.581,408.789,413.165,417.541,421.794,424.418,428.378,432.754,434.458,438.834,442.794,444.498,448.498,450.197,452.405,455.029,459.405,463.781,465.989,472.613,476.989,481.365,483.613,485.233,489.609,493.985,498.361,500.985,505.361,509.737,514.113,518.489,521.006,525.382,529.758,533.718,538.134,539.771,541.475,545.8910000000001,547.595,552.883,555.091,559.467,561.171,565.547,569.923,571.627" y="54.20500000000004" svg_rhmargin="576.043" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">Prevalence and determinants of anti-tuberculosis treatment non-adherence in Ethiopia</text>
  <path d=" M 36.0 48.00019836425781 L 576.0 48.00019836425781 L 576.0 47.50019836425781 L 36.0 47.50019836425781" style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <path d=" M 81.58110046386719 34.92279815673828 L 237.88299560546875 34.92279815673828 Z " style="fill:none;stroke:#000000;stroke-width:9.999999747378752E-5;"/>
  <text x="36.0,41.288,45.664,51.872,57.2,58.847,65.055,70.759,76.087,77.782,79.862,81.58,85.956,88.164,90.372,94.748,98.708,100.916,103.124,105.332,109.708,114.084,115.788,117.996,122.372,124.893,129.269,131.477,135.853,140.229,142.437,146.813,151.189,155.451,159.827,162.035,163.739,168.115,172.491,175.115,179.491,183.867,185.571,187.779,192.155,196.44,200.816,205.191,207.399,211.775,216.151,220.527,224.903,229.151,233.527,237.94299999999998,245.876,249.836,254.212,258.588,262.964,267.34,269.964,273.964,275.639,280.015,284.391,286.639,288.338,292.714,297.09,301.466,305.882,552.81,557.185,561.601,563.241,565.489,567.209,571.585" y="764.0" svg_rhmargin="576.001" style="fill:#000000;font-family:Helvetica;font-size:8.0px;font-style:NORMAL;font-weight:normal;">PLOS ONE | https://doi.org/10.1371/journal.pone.0210422 January 10, 2019 14 / 15</text>
 </g>
</svg>
